Stocks and Investing
Stocks and Investing
Tim Chiang Downgraded (TEVA) to Hold on, Jan 18th, 2018
Tim Chiang of BTIG, Downgraded "Teva Pharmaceutical Industries Limited" (TEVA) to Hold on, Jan 18th, 2018.
Tim has made no other calls on TEVA in the last 4 months.
There are 11 other peers that have a rating on TEVA. Out of the 11 peers that are also analyzing TEVA, 5 agree with Tim's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- David Risinger of "Morgan Stanley" Upgraded from Sell to Hold on, Friday, December 15th, 2017
- Vamil Divan of "Credit Suisse" Upgraded from Sell to Hold on, Friday, December 15th, 2017
- Rohit Vanjani of "Guggenheim" Initiated at Hold and Held Target at $16 on, Tuesday, December 12th, 2017
- Gregg Gilbert of "Deutsche Bank" Downgraded from Strong Buy to Hold on, Friday, November 3rd, 2017
- Douglas Tsao of "Barclays" Maintained at Hold with Decreased Target to $19 on, Friday, October 20th, 2017
These are the ratings of the 6 analyists that currently disagree with Tim
- Irina Rivkind Koffler of "Mizuho" Upgraded from Hold to Strong Buy on, Tuesday, January 9th, 2018
- Jacob Hughes of "Wells Fargo" Downgraded from Hold to Sell on, Friday, January 5th, 2018
- Liav Abraham of "Citigroup" Upgraded from Hold to Strong Buy on, Thursday, January 4th, 2018
- Ami Fadia of "Leerink Swann" Initiated at Sell and Held Target at $15 on, Tuesday, January 2nd, 2018
- Jami Rubin of "Goldman Sachs" Upgraded from Hold to Strong Buy on, Friday, December 15th, 2017
- Chris Schott of "JP Morgan" Downgraded from Hold to Sell on, Monday, November 13th, 2017
Contributing Sources
Similar Stocks and Investing Articles
[ 12:00 AM ] - WOPRAI